乐心医疗收盘上涨3.50%，滚动市盈率43.75倍，总市值30.90亿元

Group 1 - The core business of the company is health IoT and digital health services, with main products including smart electronic blood pressure monitors, electronic health scales, smart blood glucose monitoring products, fat measuring devices, ECG monitoring equipment, smart bands, and smart watches [2] - The company is recognized as a national high-tech enterprise and has established several research and development centers, focusing on the R&D, production, and sales of home medical health electronic products [2] - The latest financial report indicates that for Q1 2025, the company achieved a revenue of 273 million yuan, representing a year-on-year increase of 9.90%, and a net profit of 22.94 million yuan, reflecting a year-on-year growth of 67.88% with a gross profit margin of 37.38% [2] Group 2 - As of April 29, the company's stock closed at 14.21 yuan, up 3.50%, with a rolling PE ratio of 43.75, marking a new low in 18 days, and a total market capitalization of 3.09 billion yuan [1] - In terms of industry comparison, the average PE ratio for the medical device industry is 47.74, with a median of 36.15, placing the company at the 84th position in the industry ranking [1][3] - On April 29, the company experienced a net outflow of 2.93 million yuan in principal funds, although the overall trend over the past five days showed a net inflow of 32.09 million yuan [1]